Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
ADP-ribosylation factor (ARF)-like proteins (ARLs) comprise a functionally distinct group of the ARF family of RAS-related GTPases. Additionally we are shipping ARL2BP Antibodies (45) and ARL2BP Kits (24) and many more products for this protein.
Showing 10 out of 20 products:
Human ARL2BP Protein expressed in Escherichia coli (E. coli) - ABIN667251
Zhang, Li, Zhang, Zhong, Lai, Ding: Crystal structure of the ARL2-GTP-BART complex reveals a novel recognition and binding mode of small GTPase with effector. in Structure (London, England : 1993) 2009
Show all 2 references for ABIN667251
Alteration of EBV encoded miR-BART1 expression results in an increase in migration and invasion of nasopharyngeal carcinoma in vitro and causes metastasis in vivo. EBV-miR-BART1 directly targets the cellular tumour suppressor PTEN.
EBV also downregulates two immediate early (show JUN Proteins) genes by miR (show MLXIP Proteins)-BART20-5p.
Mutations in ARL2BP cause autosomal-recessive retinitis pigmentosa.
EBV-miR (show MLXIP Proteins)-BART1 could influence the expression of metabolism-associated genes and might be involved in cancer metabolism in nasopharyngeal carcinoma
Our results imply that BART regulates actin-cytoskeleton rearrangements at membrane ruffles through modulation of the activity of Rac1, which, in turn, inhibits pancreatic cancer cell invasion.
These results imply that BART (show BSND Proteins) contributes to regulating PKCalpha (show PKCa Proteins) activity through binding to ANX7 (show ANXA7 Proteins), thereby affecting the invasiveness of pancreatic cancer cells.
We identify a subset of BART (show BSND Proteins) miRNAs that are restricted to Latency III in normal infection but are up regulated in tumors that express Latency I and II.
Our results imply that BART (show BSND Proteins) increases active RhoA (show RHOA Proteins) by inhibiting ARL2 (show ARL2 Proteins) function, which in turn inhibits invasiveness of cancer cells.
overexpression of the amino (N)-terminal region of G3BP (show G3BP1 Proteins), including the binding region for BART (show BSND Proteins) mRNA, dominant-negatively inhibits formation of the complex between endogenous G3BP (show G3BP1 Proteins) and BART (show BSND Proteins) mRNA, and increases the expression of BART (show BSND Proteins).
Crystal structure of the ARL2 (show ARL2 Proteins)-GTP (show AK3 Proteins)-BART (show BSND Proteins) complex reveals a novel recognition and binding mode of small GTPase (show RACGAP1 Proteins) with effector.
BART is essential for the transcriptional activity and nuclear retention of STAT3 (show STAT3 Proteins)
ADP-ribosylation factor (ARF)-like proteins (ARLs) comprise a functionally distinct group of the ARF family of RAS-related GTPases. The protein encoded by this gene binds to ARL2.GTP with high affinity but does not interact with ARL2.GDP, activated ARF, or RHO proteins. The lack of detectable membrane association of this protein or ARL2 upon activation of ARL2 is suggestive of actions distinct from those of the ARFs. This protein is considered to be the first ARL2-specific effector identified, due to its interaction with ARL2.GTP but lack of ARL2 GTPase-activating protein activity.
ADP-ribosylation factor-like protein 2-binding protein
, ARF-like 2-binding protein
, ADP-ribosylation factor-like 2 binding protein
, Arf-like 2 binding protein BART1
, binder of ARF2 protein 1
, binder of Arl Two
, binder of Arl2
, ADP-ribosylation-like 2 binding protein